IDX.ASX: Start for New Managing Director and Chief Executive Officer

Start for New Managing Director and Chief Executive Officer

Stock	Integral Diagnostics Ltd (IDX.ASX)
Release Time	6 Aug 2026, 9 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Integral Diagnostics Welcomes New CEO, Jason Martinez

Key Points

Mr. Jason Martinez has commenced as the new Managing Director and CEO of Integral Diagnostics
Martinez brings over 20 years of experience in diagnostic imaging and health sectors
He previously served as Executive General Manager at I-MED Radiology, overseeing significant growth and acquisitions

Full Summary

Integral Diagnostics Ltd (ASX: IDX) has announced that Mr. Jason Martinez has started his role as the new Managing Director and Chief Executive Officer. Martinez's appointment follows his announcement on 10 November 2025. He brings over 20 years of experience in the diagnostic imaging, health, and medical sectors, most recently serving as Executive General Manager for I-MED Radiology in NSW, ACT, and WA. In this role, he oversaw significant acquisitions, generated growth, improved efficiency, and enhanced patient and radiologist engagement. Martinez expressed his excitement about joining IDX and his commitment to delivering excellent healthcare and strong outcomes for investors.

Outlook

Mr. Martinez and the CFO will present IDX's FY26 audited financial results on 25 August 2026.